These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 27676327

  • 1. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
    García-Pedraza JÁ, García M, Martín ML, Eleno N, Morán A.
    J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327
    [Abstract] [Full Text] [Related]

  • 2. Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat.
    López C, Gómez-Roso M, García-Pedraza JÁ, Martín ML, Morán A, García-Domingo M.
    Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
    [Abstract] [Full Text] [Related]

  • 3. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M, Morán A, Martín ML, Ortizde Urbina AV, San Román L.
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
    [Abstract] [Full Text] [Related]

  • 4. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
    García-Pedraza JA, García M, Martín ML, Rodríguez-Barbero A, Morán A.
    Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
    [Abstract] [Full Text] [Related]

  • 5. Blockade of 5-HT2 receptors with sarpogrelate uncovers 5-HT7 receptors inhibiting the tachycardic sympathetic drive in pithed rats.
    Hernández-Abreu OI, García-Pedraza JÁ, Rivera-Mancilla E, Villanueva-Castillo B, Morán A, García-Domingo M, Manrique-Maldonado G, Altamirano-Espinoza AH, Villalón CM.
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):403-411. PubMed ID: 31846086
    [Abstract] [Full Text] [Related]

  • 6. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
    García-Pedraza JÁ, García M, Martín ML, Gómez-Escudero J, Rodríguez-Barbero A, Román LS, Morán A.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):65-73. PubMed ID: 23769743
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.
    García-Domingo M, García-Pedraza JÁ, Fernández-González JF, López C, Martín ML, Morán A.
    Int J Mol Sci; 2022 May 20; 23(10):. PubMed ID: 35628547
    [Abstract] [Full Text] [Related]

  • 8. Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow.
    García-Pedraza JÁ, Hernández-Abreu O, García M, Morán A, Villalón CM.
    Can J Physiol Pharmacol; 2018 Apr 20; 96(4):328-336. PubMed ID: 28886249
    [Abstract] [Full Text] [Related]

  • 9. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM, Centurión D, Rabelo G, de Vries P, Saxena PR, Sánchez-López A.
    Br J Pharmacol; 1998 Jul 20; 124(5):1001-11. PubMed ID: 9692787
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
    Sánchez-Lopez A, Centurión D, Vázquez E, Arulmani U, Saxena PR, Villalón CM.
    Br J Pharmacol; 2003 Oct 20; 140(4):725-35. PubMed ID: 14504136
    [Abstract] [Full Text] [Related]

  • 11. Peripheral 5-HT1A and 5-HT7 serotonergic receptors modulate parasympathetic neurotransmission in long-term diabetic rats.
    Restrepo B, Martín ML, San Román L, Morán A.
    Exp Diabetes Res; 2010 Oct 20; 2010():686734. PubMed ID: 21403818
    [Abstract] [Full Text] [Related]

  • 12. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
    García M, Morán A, Calama E, Martín ML, Barthelmebs M, Román LS.
    Br J Pharmacol; 2005 Jul 20; 145(5):593-601. PubMed ID: 15852039
    [Abstract] [Full Text] [Related]

  • 13. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
    García-Pedraza JÁ, García M, Martín ML, San Román L, Morán A.
    Eur J Pharmacol; 2014 May 15; 731():80-7. PubMed ID: 24675150
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.
    García-Pedraza JÁ, Morán A, Martín ML, Ollauri-Ibáñez C, Rodríguez-Barbero A, Villalón CM, García-Domingo M.
    Pflugers Arch; 2020 Dec 15; 472(12):1693-1703. PubMed ID: 32820344
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats.
    García M, García-Pedraza JÁ, Villalón CM, Morán A.
    Basic Clin Pharmacol Toxicol; 2016 Feb 15; 118(2):113-21. PubMed ID: 26301462
    [Abstract] [Full Text] [Related]

  • 16. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat.
    Morán A, Fernández MM, Velasco C, Martín ML, San Román L.
    Br J Pharmacol; 1998 Mar 15; 123(6):1205-13. PubMed ID: 9559906
    [Abstract] [Full Text] [Related]

  • 17. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M, Ito H, Kamato T, Miyata K.
    Arch Int Pharmacodyn Ther; 1995 Mar 15; 330(2):177-89. PubMed ID: 8861711
    [Abstract] [Full Text] [Related]

  • 18. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
    García-Pedraza JÁ, García M, Martín ML, Morán A.
    Vascul Pharmacol; 2015 Sep 15; 72():172-80. PubMed ID: 26003124
    [Abstract] [Full Text] [Related]

  • 19. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
    Fernández-González JF, García-Pedraza JÁ, Terol-Úbeda AC, Martín ML, Morán A, García-Domingo M.
    Biomed Pharmacother; 2024 Jul 15; 176():116814. PubMed ID: 38820974
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart.
    Morán A, Velasco C, Martín ML, San Román L.
    Eur J Pharmacol; 1994 Feb 03; 252(2):161-6. PubMed ID: 8157057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.